4 pending office actions • 4 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 7 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 4 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 4 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (75%) |
| §112 only | 1 (25%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| AULAKH, CHARANJIT | 1 | 80.9% | -15.6% |
| CHICKS, ASHLI ARIANA | 1 | 64.1% | +44.9% |
| SHOWALTER, ALEXANDER KEITH | 1 | 52.1% | +53.0% |
| ZINGARELLI, SANDRA | 1 | 8.0% | +45.7% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18566227 | BENZIMIDAZOLE COMPOUND OR SALT THEREOF, CANINE FILARIASIS CONTROL AGENT CONTAINING SAME, AND METHOD OF USE THEREOF | AULAKH, CHARANJIT | 18d overdue |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17669888 | MICROBIAL COMPOSITIONS FOR THE PREVENTION OR REDUCTION OF GROWTH OF FUNGAL PATHOGENS ON PLANTS | ZINGARELLI, SANDRA | 16d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17669888 | MICROBIAL COMPOSITIONS FOR THE PREVENTION OR REDUCTION OF GROWTH OF FUNGAL PATHOGENS ON PLANTS | ZINGARELLI, SANDRA | 16d overdue |
| 18566306 | BENZIMIDAZOLE COMPOUND OR SALT THEREOF, CANINE FILARIASIS CONTROL AGENT CONTAINING SAME, AND METHOD OF USE THEREOF | CHICKS, ASHLI ARIANA | 4d overdue |
| 18566534 | BENZIMIDAZOLE COMPOUND OR SALT THEREOF, CANINE FILARIASIS CONTROL AGENT CONTAINING SAME, AND METHOD OF USE THEREOF | SHOWALTER, ALEXANDER KEITH | 9d |
| Art Unit | Apps |
|---|---|
| 1621 | 1 |
| 1626 | 1 |
| 1629 | 1 |
| 1653 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18566227 | BENZIMIDAZOLE COMPOUND OR SALT THEREOF, CANINE FILARIASIS CONTROL AGENT CONTAINING SAME, AND METHOD OF USE THEREOF | AULAKH, CHARANJIT | 1621 | §103 | Non-Final OA | 18d overdue | Pending | Dec 01, 2023 |
| 18566306 | BENZIMIDAZOLE COMPOUND OR SALT THEREOF, CANINE FILARIASIS CONTROL AGENT CONTAINING SAME, AND METHOD OF USE THEREOF | CHICKS, ASHLI ARIANA | 1626 | §103 | Non-Final OA | 4d overdue | Pending | Dec 01, 2023 |
| 18566534 | BENZIMIDAZOLE COMPOUND OR SALT THEREOF, CANINE FILARIASIS CONTROL AGENT CONTAINING SAME, AND METHOD OF USE THEREOF | SHOWALTER, ALEXANDER KEITH | 1629 | §112 | Non-Final OA | 9d | Pending | Dec 01, 2023 |
| 17669888 | MICROBIAL COMPOSITIONS FOR THE PREVENTION OR REDUCTION OF GROWTH OF FUNGAL PATHOGENS ON PLANTS | ZINGARELLI, SANDRA | 1653 | §103 | Final Rejection | 16d overdue | Pending | Feb 11, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial